Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.275
+0.075 (1.79%)
At close: Jun 26, 2026, 4:00 PM EDT
4.400
+0.125 (2.92%)
After-hours: Jun 26, 2026, 4:51 PM EDT
Bolt Biotherapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Bolt Biotherapeutics stock have an average target of 34.67, with a low estimate of 7.00 and a high estimate of 75. The average target predicts an increase of 710.98% from the current stock price of 4.28.
Analyst Consensus: Buy
* Price targets were last updated on May 28, 2026.
Analyst Ratings
The average analyst rating for Bolt Biotherapeutics stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 0 | 1 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jun 25, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $22 | Buy | Initiates | $22 | +414.61% | May 28, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +63.74% | May 28, 2026 |
| Lake Street | Lake Street | Buy Maintains $75 | Buy | Maintains | $75 | +1,654.34% | May 13, 2026 |
Financial Forecast
Revenue This Year
1.51M
from 7.70M
Decreased by -80.39%
Revenue Next Year
3.50M
from 1.51M
Increased by 131.99%
EPS This Year
-238.28
from -17.06
EPS Next Year
-254.96
from -238.28
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.5M | 7.0M | |
| Avg | 1.5M | 3.5M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -41.2% | 364.0% | |
| Avg | -80.4% | 132.0% | |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -238.28 | -254.96 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.